Tnkase Kit
Product Images NDC 50242-014

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Tnkase (NDC 50242-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Kit Carton)

TNKase is a medication used for intravenous use after reconstitution. It is indicated for the treatment of ST elevation myocardial infarction (STEMI). Each kit contains one 50 mg vial of TNKase, one 10 mL vial of preservative-free sterile water for injection, USP, and prescribing information. The vial of TNKase contains 50 mg of tenecteplase along with other components such as arginine, phosphoric acid, and polysorbate 20. This medication is produced by Genentech.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.